about $500 (Omidria's sales price
plus 6%).
Omidria's FDA approval ensures
it's safe for use in patients, which
isn't always the case with com-
pounded mydriatics, says Dr.
Hamilton, who calls Omidria an
"excellent option" for maintaining
intraoperative miosis, and says
the CMS carve out should make
the drug available for more wide-
spread use.
Rings and expansion
devices
Are devices that stretch the iris
and expand the pupil more reli-
able than mydriatic agents? Dr.
Hamilton thinks so. "There's no
question that they will provide
dilation," he says. "That's not
always true with pharmaceutical
agents. Injecting Shugarcaine in
patients with risk factors for
small pupils might not have much
impact on maintaining mydriasis."
Surgeons look for several fea-
tures when assessing the func-
tionality of pupil expansion
devices, says Dr. Miller, including
Call: (844) 820-8940
Email: customerservice@oasismedical.com
Register: www.oasismedical.com
From the company that brought your practice
Oasis Tears
®
and Oasis names & logos are registered trademarks of OASIS
®
Medical, Inc. 514 S Vermont Ave, Glendora, CA 91741.
LIT-SRG-Ad-OS-Jan2019 Rev.0 12.2018
True Surgical Solutions.
OASIS
®
Iris Retractor Round Hooks
Ref#: 4460 (5 pk)
AVAILABLE
:
Q1 2019
OASIS
®
Iris Retractor Rectangular Hooks
Ref#: 4461 (5 pk)
OASIS
®
Iris Retractor Twin Hooks
Ref#: 4462 (5 pk)
Introducing
OASIS
®
IRIS RETRACTORS
